Thermo Fisher Scientific Extends Latin America Network with new Chilean Partner for Informatics
News Apr 30, 2008
The new distribution agreement allows Alta Tecnología to support sales activities in Chile, Paraguay, Uruguay and Bolivia for the Thermo Scientific portfolio of informatics products which are focused on the process industries and analytical laboratories, including Nautilus LIMS™, Sample Manager LIMS™ and Atlas CDS™.
Dedicated sales experts will target those industries which are strong in the region, and which Thermo Fisher Scientific has long served, including the mining, pharmaceutical, petrochemical and chemical markets.
Oliver Faidi Cortes, director of sales in Latin America & Caribbean Thermo Fisher Scientific, comments, “With distributors already located strategically across Latin America, this new partnership demonstrates our commitment to further expanding and improving our services in this geography. Headquartered in Santiago de Chile, Alta Tecnología has developed a deep knowledge of local businesses across Chile, Bolivia, Paraguay and Uruguay, and the Thermo Scientific Informatics products through training. This perfectly positions Alta Tecnología to further promote and support our informatics portfolio for both new and existing customers.”
Gonzalo Gonzalez, of Alta Tecnología, confirms, “Alta Tecnología focuses on the Latin American market, currently specializing in mass spectroscopy, spectroscopy and elemental analysis. We already represent Thermo Fisher Scientific in Uruguay, Paraguay and Bolivia for mass spectrometry; chromatography; spectroscopy and elemental analysis products; and are responsible for the spectroscopy products (UV-VIS and IR) in Chile. Alta Tecnología will offer sales and technical support for the informatics portfolio, bringing a dedicated local approach to the Thermo Fisher activity in the region.”
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE